Business

US FDA orphan designation received for cutaneous porphyrias

US FDA orphan designation received for cutaneous porphyrias

articleClinuvel Pharmaceuticals LimitedFebruary 11, 20165/company/clinuvel-pharmaceuticals-ltd/news/us-fda-orphan-designation-received-for-cutaneous-porphyrias
US FDA orphan designation received for cutaneous porphyrias

About this update from Clinuvel Pharmaceuticals Limited

[{"type":"text","content":"Clinuvel Pharmaceuticals Ltd has released a press release. View Attachment","length":259,"tagName":"div"}]

More updates from Clinuvel Pharmaceuticals Limited